Blueberries Medical Finalizes C$1.1 Million Private Placement

Blueberries Medical Corp., a Toronto-based company focused on cannabis derivatives, announced the closing of a C$1.1 million non-brokered private placement. The placement, involving 84,615,385 common shares at C$0.013 per share, aims to fund operation expansions and general corporate purposes.

The investment was led by Terraflos Inc., chaired by Facundo Garreton, also Blueberries' CEO. Through this offering, Mr. Garreton's shares increased to 396,326,486, representing approximately 67.98% of the company's common shares.

The transaction was classified as a "related party transaction" but was exempt from requiring minority approval. The funds are earmarked to boost Blueberries' offerings and scale its operations in Latin America.